The Discounted Cash Flow (DCF) valuation of Boston Scientific Corp (BSX) is 65.61 USD. With the latest stock price at 43.92 USD, the upside of Boston Scientific Corp based on DCF is 49.4%.
Based on the latest price of 43.92 USD and our DCF valuation, Boston Scientific Corp (BSX) is a buy. buying BSX stocks now will result in a potential gain of 49.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.2% | 7.2% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 43.34 - 127.29 | 65.61 |
| Upside | -1.3% - 189.8% | 49.4% |